Bee Vectoring Technologies International Inc. announced that it has secured its first revenue commitments with US sunflower growers and has successfully expanded into other activities within this crop, including demonstration and research trials. This marks significant progress in penetrating the USD 470 million sunflower market. This entry into the sunflower market is based on the successful first year results of the multi-year North Dakota State University (NDSU) trials of BVT's biological fungicide, CR-7. Funded by the North Dakota Department of Agriculture and approved by the United States Department of Agriculture (USDA), the trials are run by NDSU in cooperation with BVT. The trials provide the critical data points needed to sell in the sunflower market, where 1.3 million acres are harvested annually in America alone. Trial results proved that the system is effective and efficient for sunflower growers to use for disease control and improve yields. The results validated the technology, quantified hive distribution needed to achieve satisfactory Sclerotinia head rot control, and measured increased yield results and reduced sclerotia contamination. Data collected in the first year has also enabled BVT to identify the segments of the sunflower industry that have the greatest potential for the Company's system: seed production and higher-value contracted oil and confectionary production. BVT will continue the state-funded trials through the next two growing seasons, starting this August, to further refine recommendations for hive/dispenser numbers and placements, and further strengthen the BVT value proposition and ROI for growers. Originally approved for two years, these state-funded trials have just been extended for an additional third year.